It shows total disrespect for retail shareholders (no other way to put it).
The best thing the company achieved was to 'enlighten' medical device inventors to do a 'heads-up' to radical new type of tech that may well be the next step in surgical robotics.
Currently, maybe best thing that can happen is someone buys up their patents, and moves forward medical science?
I . . . and many others seemingly are coming to doubt this wunderkind tech team . . . as evident by lack of solid PR news and stock daily volume?
The basic tech concept (looking inside small diameter tubes for stage of debris buildup) would be great spur to reducing industrial as well as medical pipe repair and function costs. Imagine being able to time rate repair costs budgets real-time, even with first-generation products.
Developing worldwide patent portfolio means nothing, if you do not have legal talent and budget to defend them.
One can wonder what is MBOT notion of Town Meetings . . . standing on a freeway traffic light corner and waving a sign?
Recent MBOT News
- Microbot Medical Announces Positive Results from the First Phase of its Collaboration with Corewell Health™ • GlobeNewswire Inc. • 04/29/2024 12:30:00 PM
- Microbot Medical Shares Status Following Recent Geopolitical Events • GlobeNewswire Inc. • 04/15/2024 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 11:41:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 11:41:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 11:41:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 11:41:08 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 02/20/2024 09:35:10 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 07:49:35 PM
- Microbot Medical Submits an IDE Application to Gain FDA Approval to Commence Its Pivotal Clinical Trial in the US • GlobeNewswire Inc. • 02/05/2024 12:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/30/2024 09:30:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/30/2024 12:20:27 PM
- Microbot Medical Announces Settlement and Release Agreement, Effectively Resolving all Associated Legal Matters • GlobeNewswire Inc. • 01/30/2024 12:20:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 01/26/2024 05:15:33 AM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 01/22/2024 10:20:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/18/2024 12:20:26 PM
- Microbot Medical Expands US Clinical Infrastructure in Support of the Upcoming IDE Submission to Commence its First in Human Clinical Study • GlobeNewswire Inc. • 01/18/2024 12:20:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/12/2024 09:20:41 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 01/12/2024 09:16:06 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/02/2024 10:00:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2024 09:55:51 PM
- Microbot Medical Announces Exercise of Outstanding Preferred Investment Options for $2.73 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules • GlobeNewswire Inc. • 12/29/2023 01:00:00 PM
- Microbot Medical Announced Positive Results of Its GLP Pivotal Pre-Clinical Study Where All Study Objectives Were Met • GlobeNewswire Inc. • 12/28/2023 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/14/2023 01:15:27 PM
- Microbot Medical and Corewell Health Forge Collaboration to Establish the LIBERTY® Endovascular Robotic Surgical System for Telerobotic • GlobeNewswire Inc. • 12/14/2023 01:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/07/2023 01:00:28 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM